According to a scientific paper published in the European Journal of Human Genetics, approx. 300 million people (around 3.5-5.9%) are living with rare diseases, out of which 72% are genetic, and of those 70% start in childhood. A greater understanding of biology with the rapid adoption of revolutionary diagnostic and therapeutic technologies has unlocked treatment options for people with rare diseases. Many
High investments for research and development activities and rise in genetic diseases is expected to drive the demand for United States precision medicine market for the forecast period. According to TechSci Research report, “United States Precision Medicine Market By Products and Services (Precision Medicine Platforms, Precision Medicine Tools, Precision Medicine Services) By Technology (Big Data Analytics, Artificial
Increasing advancements in cancer biology and myriad benefits offered by precision medicines to drive the global precision medicine market. According to TechSci Research report, “Global Precision Medicine Market By Products and Services (Precision Medicine Platforms, Precision Medicine Tools, Precision Medicine Services), By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Whole Genome Sequencing, Companion Diagnostics, Next
Increasing advancements in cancer biology and myriad benefits offered by precision medicines to drive global precision medicine market According to TechSci Research report, “Global Precision Medicine Market By Technology (Artificial Intelligence, Whole Genome Sequencing, Companion Diagnostics, Genome Sequencing, Big Data Analytics, Molecular Imaging, Digital PCR, Microarray, CRISPR and Others), By Applications (Cardiology, Oncology, Respiratory, Immunology
